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Clinical diagnosticsWe used a RainDance Technologies (RDT) expanded content library to enrich the human X chromosome exome
(2.5 Mb) from26male samples followed by Illumina sequencing. Ourmultiplex primer library covered 98.05% of
the humanX chromosomeexome in a single tubewith11,845different PCR amplicons. Illumina sequencing of 24
male samples showed coverage for 97% of the targeted sequences. Sequence from 2 HapMap samples conﬁrmed
missingdata rates of 2–3%at sites successfully typedby theHapMapproject,with anaccuracy of at least ~99.5% as
compared to reportedHapMapgenotypes. Our demonstration that a RDT expanded content library can efﬁciently
enrich and enable the routine sequencing of the human X chromosome exome suggests a wide variety of
potential research and clinical applications for this platform.Genetics, Emory University,
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Recent technological advances have dramatically reduced costs
while increasing the throughput of DNA sequencing (see reviews in
[1–3]). These changes in DNA sequencing have stimulated research
focused on improving methods of target DNA isolation from complex
eukaryotic genomes [4–15]. One promising approach of DNA target
selection builds upon advances in microdroplet-based technology
that is currently being developed by RainDance Technologies (RDT)
[16]. This methodology used a highly controlled system to create
emulsions containing reactive compounds that allow an enormous
number of deﬁned reactions to be carried out in parallel. An initial
application of this technology demonstrated the ability to perform in
parallel greater than 1 million simplex PCR reactions targeting up to
4000 distinct amplicons in order to generate target DNA for a second
generation sequencing platform [11]. A recent study demonstrated
the use of a library of 10,280 distinct amplicons to target 437 target
genes that when mutated cause severe childhood recessive diseases
[17].
While these original experiments were very successful, sequenc-
ing the entire coding content of human chromosomes may be of
interest for both research and clinical applications and requires the
validation of even larger RDT libraries. For example, the human
X chromosome is replete with loci that when mutated can result inintellectual disability (ID) [18,19]. Autism spectrum disorders (ASDs)
display a profound male excess, much like ID, the causes of which
remain largely undiscovered, although there is growing evidence for a
role of X-linked variation in at least some cases of ASD [20–22]. While
recent resequencing studies of the human X chromosome in patients
with ID or ASD have resulted in a number of exciting ﬁndings, their
reliance on traditional PCR-based methods of target DNA ampliﬁca-
tion were limiting [21,23,24]. Mutations at the X-linked dystrophin
(DMD) locus, the largest gene in the human genome, result in Becker
and Duchenne muscular dystrophies. Identifying the varying classes
of functional mutations, at dystrophin or other clinically signiﬁcant
X-linked loci, remains a signiﬁcant challenge for clinical diagnostic
testing [25–27].
We have therefore focused on determining if RDT's microdroplet-
based technology could be used to efﬁciently sequence the human
X chromosome exome. A project targeting the human X chromosome
exome (~2.5 Mb) would require approximately a 12,000 distinct PCR
amplicons. To address these larger target regions, RainDance
Technologies developed expanded content libraries which allow up
to 5 primer pairs within each primer droplet and maintain single plex
PCR by limiting the amount of genomic DNA within the PCR reaction,
with no other changes in the standard workﬂow. Here we validate a
custom-designed RDT expanded content library with 3 sets of primers
in each droplet in order to perform the efﬁcient targeted resequencing
of the human X chromosome exome. By combining the RDT expanded
content library with the Illumina Genome Analyzer sequencing
platform, our results show that it is possible to sequence multiple
human X chromosome exomes with high uniformity and accuracy,
while at the same time minimizing sequencing costs. This approach
will likely prove invaluable for researchers and clinicians in a wide
variety of applications that require the systematic sequencing of all
the coding and non-coding exons of the human X chromosome.
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2.1. Primer library design process
We obtained the target sequence for the human X chromosome
exome from the UCSC genome browser RefSeq Genes track (hg18
build). The total reference sequence consisted of 7427 fragments with
a total size of 2,495,062 bases and included all coding and non-coding
(3′ and 5′ untranslated regions) exons of human chromosome X. To
enable greater than 4000 unique primer pairs within a primer library
the RainDance Primer Design Pipeline was modiﬁed to evaluate each
primer pair to determine the ability to pool up to 5 primer pairs within
the same primer droplet. The number of amplicons offered in an
expanded content RDT primer library ranges from 4000 to 20,000
unique primer pairs. Since the human X chromosome exome design
required less than 12,000 primers, we chose to optimize 3 primer
pairs per droplet. The custom primer library was designed using the
manufacturer's design parameters (RainDance Technologies, Lexing-
ton, MA, USA) and the Primer3 algorithm (http://primer3.source-
forge.net/). All SNPs from dbSNP build 129 were ﬁltered from the
primer selection region. Repeat masking was not performed on the
input regions to the primer design pipeline. The primer design
pipeline performed an exhaustive primer selection across all of the
regions submitted.
After the primers were selected, duplicate amplicons and their
associated primers were removed from the full design and only
unique regions were kept in the collapsed design. A total of 11,845
unique amplicons were required to cover the entire targeted human
X chromosome exome (Table 1). Filtering of these amplicons led us to
reject 27 primer pairs whose design parameters were too extreme to
meet the stringent primer picking criteria used by RDT. An additional
242 amplicons and their associated primer pairs were deleted from
the design because they were predicted to produce more than 3
products in the human genome.
Primer pairs were pooled based on the proximity of each primer
pair's target within the genome. Each of the primer's are evaluated for
off target products using the re-PCR algorithm for each of the 6
primer–primer interactions within each pool. Once pools of 3 primer
pairs were determined, each pool was processed within the Rain-
Dance Primer Library Manufacturing process. Then each pooled
primer pair aliquot was processed to create an emulsion containing
an equal representation of each of the 3 primer pairs within a unique
primer droplet.
The ﬁnal human X chromosome exome RDT expanded content
primer library consisted of 11,576 amplicons and associated primer
pairs, or 97.7% of the initial design (Table 1). The full length of DNA
ampliﬁed was predicted to be 5,916,297 bases. In total, 98.05% of the
targeted human X chromosome exome bases (2,446,304 out of
2,495,062) were covered by at least one amplicon (Table 1). After
accounting for overlapping amplicons, a reference sequence consist-
ing of 5748 fragments with a total size of 4,723,733 bp was generated
and used for mapping.
2.2. Sample selection
We chose 24 male samples from SFARI's Simplex Collection, New
York, NY, USA. The SFARI Simplex Collection (SSC) is a core projectTable 1
Design summary for human chromosome X exome RDT Library.
Total size of target region 2,495,062 bp
Size of region covered by RDT library 2,446,304 bp
Percent of region covered by RDT library 98.05%
Total number of amplicons to cover target region 11,845
Final number of amplicons in RDT library 11,576
Percent of amplicons in RDT library 97.7%and resource of the Simons Foundation Autism Research Initiative
(SFARI). SSC has a permanent repository of genetic samples from
approximately 3000 families, each of which has one child affected
with Autism Spectrum Disorder (ASD), one unaffected child, and two
parents unaffected with ASD. Two male HapMap samples, NA18500
and NA18503, were also enriched and sequenced in order to compare
HapMap genotype calls with those from our Illumina sequencing.
Prior to processing, patient and control DNA samples were quantiﬁed
by measuring OD260/280 using a NanoDrop instrument. Following
quantiﬁcation, 100 ng of DNA, as determined by the NanoDrop, were
run on a 0.8% agarose gel to verify that the DNAwas of high molecular
weight. A total of 26 genomic DNA samples (2 HapMap males as
control and 24 Autistic patients DNA) passing quality control were
send to RDT facility and were then processed on the RDT 1000 with
the RDT Sequence Enrichment Application using standard RDT
procedures for genomic DNA.
2.3. Genomic DNA fragmentation
Genomic DNA samples were fragmented using a nebulization kit
(Invitrogen, Carlsbad, CA, USA, catalog # K7025-05) following the
manufacturer's recommended protocol: 2.5 μg of genomic DNA was
re-suspended in 750 μL Shearing Buffer (TE, pH 8.0, Fisher, Worcester
MA, USA, catalog # 50843207) containing 10% glycerol (Fisher,
catalog # AC15892) and was nebulized at 6–10 pounds per square
inch (psi) for 90 s to produce 2–4 kb DNA fragments. Fragmentation
of the genomic DNA to 2–4 kb allows for optimal template size for
performing PCR in droplets. Sheared genomic DNA was precipitated
by adding 80 μL 3 M sodium acetate, pH 5.2 (Fisher, catalog #
50843081), 4 μL 20 mg/mL Mussel Glycogen (Fisher, catalog #
NC9329100) and 700 μL 100% isopropanol (Fisher, catalog #
AC14932) mixed and stored overnight at −20 °C. The samples were
centrifuged at themaximum speed for 15 min at 4 °C. The supernatant
was removed, 500 μL of cold 80% ethanol (Fisher, catalog # 5739852)
wash buffer was added and the DNA pellet was spun down by
centrifugation at the maximum speed for 5 min at 4 °C. The pellet was
air dried and re-suspended in 10 μL 10 mM Tris–HCL, pH 8.0 (Sigma,
St. Louis, MO, USA, catalog # T2694). Fragmented genomic DNA was
run on a 0.8% agarose gel to conﬁrm that the genomic DNA was in the
correct size range (2–4 kb).
2.4. Genomic DNA template mix
In order to prepare the input DNA template mixture for targeted
ampliﬁcation, 1.0 μg of the puriﬁed Genomic DNA Fragmentation
reaction was added to 4.7 μL 10× High-Fidelity Buffer (Invitrogen,
catalog # 11304-029), 1.26 μL of MgSO4 (Invitrogen, catalog # 11304-
029), 1.71 μL 10 mM dNTP (New England Biolabs (NEB), Ipswich, MA,
USA, catalog # NO447S/L), 3.6 μL Betaine (Sigma, catalog # B2629-
50G), 3.6 μL of RDT Droplet Stabilizer (RainDance Technologies,
Lexington, MA, USA, catalog # 30-00826), 1.8 μL dimethyl sulfoxide
(Sigma, catalog # D8418-50ml) and 0.72 μL 5 units/μL of Platinum
High-Fidelity Taq (Invitrogen, catalog # 11304-029) the samples was
brought to a ﬁnal volume of 25 μL with Nuclease Free Water, Teknova
(Fisher, catalog # 50843418).
2.5. RDT 1000: Merge
PCR droplets were generated on the RDT1000 (RainDance
Technologies, catalog # 20-01000) using the manufacturer's recom-
mended protocol: To process a single sample the user placed onto the
RDT1000 a single tube containing 25 μL of Genomic DNA Template
Mix, a custom primer droplet library (RainDance Technologies) and a
disposable microﬂuidic chip (RainDance Technologies). The custom
primer droplet library consists of a collection of individual primer
droplets where each primer droplet containsmatched pairs of forward
Table 2
Results of targeted sequencing of human chromosome X exome.
Sample
ID
Plex Total number
of reads
Percent of
reads that
map uniquely
Median
sequence
depth
Average
sequence
depth
Percent of
bases with
at least one
read
SSC1 1 22,540,925 53.24 129 175.5 97.87
SSC3 2 15,060,253 64.37 100 142.5 97.52
SSC4 2 11,199,304 61.75 77 101.5 97.67
SSC2 3 5,926,188 53.14 32 46.1 96.76
SSC3 3 11,488,977 64.29 77 108.6 97.49
SSC4 3 8,410,820 61.64 58 76.0 97.59
SSC1 4 4,021,807 53.52 23 31.5 97.13
SSC2 4 4,696,801 52.71 25 36.3 96.75
SSC3 4 8,953,172 64.17 60 84.5 97.49
SSC4 4 6,008,050 61.48 41 54.2 97.56
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primer library. The ﬁnal primer concentration in the PCR reaction is
0.53 uM per primer. The RDT1000 generated each PCR droplet by
pairing a single gDNA template dropletwith a single primer droplet. The
paired droplets ﬂow past an electrode embedded in the chip and is
instantly merged together. All of the resulting PCR droplets were
automatically dispensed as an emulsion into a PCR tube and transferred
to a standard thermal cycler for PCR ampliﬁcation. Each single sample
generated more than 1,000,000 single plex PCR droplets. After PCR
Ampliﬁcation the emulsion of PCR droplets were broken to release each
individual amplicon from the PCR droplets and were puriﬁed over a
QiagenMinElute column. The puriﬁed PCR product was then run on the
Agilent Bioanalyzer to conﬁrm that the amplicon proﬁle matched the
predicted histogram proﬁle (Supplemental Fig. 1).
2.6. Multiplex Illumina library preparation
After PCR puriﬁcation, ampliﬁed fragments for each individual
were repaired to blunt ends using NEB Quick blunting kit (NEB,
catalog # E1201L, 15 min RT) followed by inactivating the enzyme in
the blunting reaction by heating at 70 °C for 10 min. The PCR
fragments were then concatenated using NEB Quick ligation kit
(NEB, catalog # M2200L). Ligation was done overnight at 25 °C. After
that 5 μL of Quick T4 DNA ligase was added to the reaction was
incubated at 37 °C for one hour followed by inactivating the ligase at
65 °C for 15 min. The ligated products were made into 100 μL volume
by adding elution buffer and were then sheared using Covaris E210
(Duty cycle 10%, Intensity cycle 5, Cycle/Burst: 200, Time :180 s). The
sheared fragments were then puriﬁed using Qiagen QIAquick PCR
puriﬁcation column and was eluted in 32 μL of elution buffer. The
samples then entered the standard Illumina Genome Analyzer
multiplex library introduced preparation protocol. At the enrichment
step, a 6 base index tag was attached to each sample using PCR
following the standard Illumina protocol. Only exception is, while
purifying the adaptor ligated products we have used Invitrogen E-Gel
SizeSelect 2% (Invitrogen, catalog # G6610-02) instead of using the gel
puriﬁcation method suggested by Illumina. The enrichment was
conﬁrmed by running an Agilent BioAnalyzer 7500 DNA chip. A
quantitative qPCR was done to quantitate the library using KAPA
Library quantiﬁcation kit (KAPABiosystems, Woburn, MA, USA,
catalog # KK4824).
2.7. Illumina sequencing and data analysis
Enriched DNA was denatured and diluted to a concentration of
8 pM. Cluster generation and 70 bp single end sequencing was
performed using standard IGAII manuals and version 4 kits. We
performedmultiplex single-end sequencing of three samples per lane
of Illumina sequencing. After sequencing, the reads were mapped and
variants sites identiﬁed using EmoryMapper (Cutler and Zwick, pers.
comm.) against the reference sequence consisting of 5748 fragments
covering 4,723,773 bases. This region is larger than the actual targeted
bases (2,446,304) as RDT included some intronic and intergenic
regions to facilitate primer picking. Sequences obtained for HapMap
samples NA18500 and NA18503 base calls were compared to those
reported by HapMap using a custom perl script to assess the rates of
data completion and accuracy. The HapMap data was assumed to be
without error when estimating data accuracy.
2.8. Microarray-based Genomic Selection (MGS)
We performed MGS for the HapMap sample NA18503 twice using
the methods published previously [6,10,15]. After MGS the enriched
DNA samples were each sequenced in a single lane of an Illumina IGA
IIX (76 bp, non-multiplexed, single end). The sequence obtained for
the two replicates of sample NA18503 were each compared to thosereported by HapMap using a custom perl script to assess the rates of
data completion and accuracy [28,29]. The HapMap data was assumed
to be without error when estimating data accuracy.
3. Results
3.1. Characteristics of human X chromosome exome RDT expanded
content multiplex library design
We obtained the human X chromosome exome sequence from the
RefSeq Genes track using the UCSC genome browser (hg18 build). The
total region we targeted for enrichment and sequencing included the
coding exons and the 3′ and 5′ untranslated regions for all annotated
X chromosome genes with a total length of approximately 2.5 Mb. A
RDT library, designed to enrich the entire targeted region, consisted of
11,845 different PCR amplicons. Bioinformatic ﬁltering of these
amplicons eliminated a small percentage from the ﬁnal multiplex
primer library (as described in the Materials and methods). The ﬁnal
synthesized multiplex primer library covered 98.05% of the targeted
region and included 97.7% of the total designed amplicons (Table 1).
3.2. Illumina sequencing of RDT expanded content multiplex library
enriched samples
We next determined the optimal level of sample multiplexing that
minimizes sequencing costs while maintaining adequate coverage of
the human X chromosome exome. To do so, we enriched 4 male SSC
samples using our multiplex human X chromosome exome RDT
library. Illumina libraries were then constructed using a different
multiplex adapter for each sample. The resulting sample libraries
were then sequenced (70 basepair, single-end reads) on an Illumina
Genome Analyzer IIx in 1-plex, 2-plex, 3-plex and 4-plex conﬁgura-
tions. For all conﬁgurations, between 53% and 64% of the total reads
mapped uniquely to the human X chromosome exome reference
sequence (Table 2). As expected, increasing the number of samples
per lane sequenced reduced the median depth across the targeted
region, while variability in the number of reads per lane correlated
with the observed median depth. Finally, approximately 3% of
targeted bases had zero coverage across samples irrespective of the
level of multiplexing (Fig. 1). From our data, we concluded that the 3-
plex conﬁguration was the optimal level of sample multiplexing that
minimized our sequencing costs while maintaining adequate cover-
age of the human X chromosome exome.
We next assessed the repeatability of the RDT enrichment and
Illumina sequencing. To do so, we enriched and sequenced 18
additional male samples in a 3-plex conﬁguration and 2 samples in a
2-plex conﬁguration. One sample failed ampliﬁcation because of
insufﬁcient genomic DNA. However, the remaining 19 samples
performed as well, or better, than our original set of four test samples
described previously (Supplemental Table 1). In total, we observed that
Fig. 1. Bar graph representing percentage of uniquely mapped targeted bases in four
different SSC sample conﬁgurations (1-plex, 2-plex, 3-plex, and 4-plex) versus the
observed sequence depth.
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ampliﬁed and sequenced in at least one sample among the 24 samples
analyzed. While the types of failures were very consistent among all
samples processed, we sought to determine if ampliﬁcation or
sequencing failure was correlated with a speciﬁc sequence composi-
tion. The sequence composition of those amplicons that failed to be
sequenced in any sample (0.43%, 50 of 11,576 total amplicons) was not
signiﬁcantly different from the successful amplicons (t-test, p=0.96,
Fig. 2).
3.3. Data completion and accuracy
In order to evaluate the quality of data obtained, we evaluated the
rates of data completion and accuracy as compared to reported
genotypes for 2 HapMap samples [28,29]. We evaluated the accuracy
of variant bases called in 2 male HapMap samples (NA18500 andFig. 2. (A) UCSC genome browser view of the location of failed amplicons along chromosom
content of the amplicons.NA18503) by comparing the HapMap genotypes with our called
genotypes, assuming the HapMap call was always accurate. In both of
these samples only 2–3% of the data was missing, at sites able to be
called by HapMap, and the accuracy (agreement with HapMap calls)
was greater than 99% (Table 3). We next compared the performance
of RDT-based enrichment method with that of MGS [6,10,15]. The
results shown in Table 3 demonstrate that the MGS performance was
very similar in terms of data accuracy and missing data. However, the
MGS capture method required between 3 and 7 fold more reads to
achieve this similar level of performance as compared to RDT-based
enrichment.
4. Discussion
Choosing the best enrichment method for targeted sequencing in
research or clinical applications requires consideration of a variety of
factors. These include: the ease and reliability of the assay, the extent
of enrichment of targeted sequences, the uniformity of coverage along
the targeted sequence, the accuracy of identifying variant genotypes,
and of course, the cost effectiveness of the approach. With the
continuing rapid drop in the cost of DNA sequencing, the ability to
efﬁciently enrich targeted regions of eukaryotic genomes is likely to
contribute to novel research and clinical applications.
Our results show that a RDT expanded content library can be used
to effectively sequence the human X chromosome exome. Using our
original RDT library design, sequencing two HapMap samples shows
between 2 and 3% missing data at known segregating sites with
accuracies of at least 99.5%. While we obtain similar levels of coverage
and accuracy by performing Microarray-based Genomic Selection
(MGS), we observed that MGS required between 3 and 7 fold more
sequence per sample to achieve the same level of data accuracy and
completeness as compared to the RDT methodology. Applying the
RDT approach to a larger collection of 24 male samples from the SSC
showed that the method was reliable and rapid. On the other hand,
while the MSG protocol is somewhat slower than the RDT method-
ology, its main advantage lies in the ability to rapidly custom design a
microarray for a small number of samples [15]. In contrast, the RDT
approach is most efﬁcient when the number of samples to be
processed with a deﬁned assay is large.e X. (B) Bar graph showing proportion of failed and successful amplicons versus the GC
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64% of the total reads mapped uniquely to the human X chromosome
exome reference sequence. In our later experiments, up to 73% of
reads mapped uniquely to the human X chromosome exome
(Supplemental Table 1). One potential question that might arise is
why do so many reads fail to map to the reference sequence? The
explanation for this pattern is straightforward. After PCR ampliﬁcation
of the fragments, the standard RainDance Technologies protocol
randomly concatenates the resulting products into longer fragments
of DNA. These longer fragments are then physically sheared, end-
repaired, and subjected to library construction in preparation for
next-generation sequencing. Any resulting read that spans the
concatenation boundary will not map uniquely to the human
X chromosome exome reference sequence. An additional analysis
pipeline step that splits these reads and maps each portion to its
respective unique location would likely be able to increase the
percentage of reads mapped. However, for this analysis, we chose to
use existing tools for our analysis, recognizing that wemay fail to map
reads spanning these concatenation boundaries.
Our demonstration that a RDT expanded content library can
efﬁciently enrich and enable the routine sequencing of the human
X chromosome exome suggests a wide variety of potential research
and clinical applications of this platform. For example, routine
sequencing the human X chromosome exome in human disorders
with a male excess could help provide insight into the etiology of
X-linked genetic disorders. Furthermore, while we have focused on
the coding and non-coding exons of the X chromosomes, the size of
the ampliﬁed targets could be easily expanded to include other
regions of interest, such as conserved non-coding X-linked regions or
panels of genes from across the genome.
Finally, as the routine use of DNA sequencing for clinical
diagnostics becomes increasingly widespread, the RDT platform offers
the potential to provide rapid and reliable assays, allowing a clinic to
routinely amplify a large, but standardized suite of regions known to
harbor disease variants of interest. One strength of the RDT platform
as compared to a capture based method, MGS, is that it requires
dramatically less sequencing with comparable accuracy rates and
missing data (Table 3). This outcome presumably reﬂects the lower
variance in coverage among different fragments of the RDT method-
ology as compared to MGS. We have previously shown that better
models for selecting oligos can signiﬁcantly improve the performance
of capture based methods [15], and iterative selection combined with
empirical validation can allow investigators to rebalance capture
oligos in order to reduce the variance in capture efﬁciency still further.
In support of this, Bell et al. 2011 observed that RDT and a different
capture based method performed similarly, although their level of
recurrent primer synthesis failures for RDT (~11%)was far higher than
what we observed in our experiment (0.43%, 50 of 11,576 total
amplicons). In total, our data suggest that for new assays, RDT may
require less initial optimization as compared to a capture based
approach and may require less sequencing for comparable accuracy
and data completeness. Finally, a second advantage of a targeted
enrichment methodology like RDT is that it can be applied for the
routine targeted sequencing of large numbers of individual patients,Table 3
Results of comparing of two methods of target enrichment (RDT and MGS) followed by
Illumina sequencing with HapMap reported genotype calls.
HapMap
ID
Method of
enrichment
Number of reads
mapping
Data
accuracy
Missing
data
NA18500 RDT 2,734,713 99.53% 2.79%
NA18503 RDT 1,966,363 99.44% 2.34%
NA18503 MGS 9,349,327 99.64% 3.92%
NA18503 MGS 13,995,254 99.43% 3.37%but by standardizing the designs, the bioinformatic challenges faced
by the diagnostic laboratory can be dramatically minimized, relative
to whole human genome sequencing.
Supplementarymaterials related to this article can be found online
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